Mayne Pharma Group Ltd.

Mayne Pharma Group Ltd. is a specialty pharmaceutical company focused on the development, manufacture, and commercialization of branded and generic pharmaceutical products. Headquartered in Salisbury, Australia, the company operates globally with key segments in Women’s Health, Dermatology, and International markets. Mayne Pharma Group Ltd. provides oral drug delivery systems and contract development and manufacturing services to third-party clients, while also distributing specialty pharmaceuticals in therapeutic areas such as women’s health, dermatology, and infectious diseases. The company has a long-standing reputation for innovation in pharmaceutical solutions and maintains a diverse product portfolio across Australia, New Zealand, North America, Europe, and Asia. Its shares are traded on the CHI-X Market Australia – Limit Venue, an alternative trading platform that offers competitive pricing and efficient execution for Australian equities. Mayne Pharma Group Ltd. continues to play a significant role in advancing accessible and safe pharmaceutical treatments worldwide.